TrueBinding

11/27/2023

Alzheimer's care is on the brink of a transformative shift, offering newfound hope and possibilities.

In a proof-of-concept clinical trial, our monoclonal antibody, TB006, has exhibited unprecedented potential, showing remarkable hope in the field of Alzheimer's treatments.

In just one month of treatment, participants in our trial have experienced significant changes in cognitive function and overall well-being.

These encouraging results not only fuel our optimism but also underscore the substantial potential of TB006 to bring about lasting changes in the lives of those grappling with Alzheimer's.

Discover more testimonials from our clinical trial participants.

11/23/2023

The holiday season is traditionally a time of togetherness, joy and cherished memories.

However, it can also be a season of mixed emotions, especially for those living with Alzheimer's, their caregivers and their loved ones.

Here are some tips to make the holiday season slightly more manageable:

✅ Adjust Expectations: Embrace flexibility and adapt to your loved one's current abilities and preferences.
✅ Keep Traditions Simple: Focus on the most meaningful traditions, simplifying them to reduce stress.
✅ Familiarize Others with the Situation: Share information and insights with family and friends to create a supportive environment.

How do you and your loved ones navigate the holiday season in the presence of Alzheimer's and dementia? Share your stories and helpful tips below!

11/20/2023

Denise recently shared her impactful journey with Alzheimer's Caregivers Network, shedding light on the challenges she faced as a caregiver following her husband Brian's Alzheimer's diagnosis.

Their experience during his participation in TrueBinding's TB006 clinical trial has brought about remarkable changes in their lives.

Learn more about Denise and Brian’s story by reading the full article:

Denise shares her family’s story and the path to discovering an experimental Alzheimer’s drug that has helped improve her husband’s behavior and symptoms and given the Womble family hope.

11/17/2023

TrueBinding's pioneering efforts to redefine Alzheimer's treatment were spotlighted in the California Business Journal.

The article highlights TB006, our promising investigational treatment, and its potential not only to slow the effects of Alzheimer's Disease but reverse disease progression.

Despite the multifaceted challenges of Alzheimer's, our clinical trial has delivered
positive outcomes and results that raise hope in the battle against this relentless
disease.

Read the full article to learn more about TrueBinding's pursuits in combating
Alzheimer's:

A serious form of dementia, Alzheimer’s Disease progresses slowly. Over time, it robs those affected of their memories, cognition, motor skills and

11/13/2023

This month, we celebrate National Family Caregivers Month, a dedicated time to honor exceptional individuals who provide unwavering support to their loved ones, especially those facing the challenges of Alzheimer's and dementia.

The journey of Alzheimer's and dementia care is fraught with unique challenges, and family caregivers for these conditions often shoulder a profound burden.

We extend our deepest gratitude to these caregivers, who confront the intricacies of memory loss and cognitive decline with an unwavering spirit of hope and boundless compassion.

Join us this month in celebrating and supporting family caregivers by sharing your stories of gratitude in the comments below!

11/11/2023

This Veterans Day, we pay tribute to the immense sacrifices and unwavering dedication of our American veterans.

Among the challenges they face, Alzheimer's is a growing concern, affecting nearly half a million veterans.

According to the Alzheimer’s Association, in 2022, an estimated 451,000 veterans lived with Alzheimer’s, and over 130,000 new cases were diagnosed.

The Alzheimer’s Association also states that the U.S. Department of Veterans Affairs projects by 2033, the number of veterans living with Alzheimer’s dementia will increase by 8.4% to exceed 488,000.

As we honor our heroes, let us also raise awareness and provide support to our veterans impacted by Alzheimer's, ensuring they receive the care and recognition they deserve.

11/06/2023

Healthcare Business Today featured TrueBinding's potentially groundbreaking investigational treatment, TB006, while highlighting the growing significance of early and regular Alzheimer's screenings as the elderly population expands.

The article explores the significance of this development, accentuating TB006's
potential capacity to reverse Alzheimer's disease, setting it apart in biotechnology
research.

In clinical trials, patients experienced improved cognitive function in Alzheimer's, unlike treatments that decelerate disease progression.

Gain deeper insights into TrueBinding's TB006, by reading the full article:

Right now, human clinical trials and an Expanded Access Program (EAP) are underway for TB006, an investigational medication for the treatment of Alzheimer’s

11/02/2023

Today, on International Stress Awareness Day, we're shining a light on the vital connection between stress and Alzheimer's and dementia.

According to Harvard Health, research has shown that chronic stress can lead to increased inflammation, raising the risk of Alzheimer's and dementia.

Stress is a part of life, but there are methods to manage it and lessen its impact on our mental well-being.

✅ Try mindfulness and meditation
✅ Stay physically active
✅ Lean on a support system of friends and family
✅ Seek professional help when needed

Learn more at truebinding.com.

10/29/2023

As we advocate for research and solutions in the field of neurodegenerative diseases, we underscore the significance of staying informed about factors that impact brain health, including strokes.

While our primary focus is on neurodegenerative diseases, we understand strokes are another critical aspect of brain health. Like Alzheimer’s and dementia, strokes can have life-altering effects.

Join in on the discussion and comment your thoughts below!

10/25/2023

TrueBinding recognizes the critical importance of nutrition in neurological health.

The New York Times recently published an article shedding light on the powerful role of certain foods in potentially reducing the risk of dementia.

From walnuts improving cognitive function to blueberries boosting memory, the article discusses the 'brain-boosting' qualities of specific foods.

We believe that staying informed about the impact of diet on brain health is a vital part of TrueBinding’s mission. Click to read the full article!

Here’s what the science says about whether your diet can counteract cognitive decline.

10/23/2023

Alzheimer's disease affects millions of lives, and it's important to recognize that almost two-thirds of Americans living with Alzheimer's are women.

This gender disparity is a sobering fact that highlights the need for greater awareness and research into Alzheimer's, particularly its impact on women.

By understanding the unique challenges women face in the battle against Alzheimer's, we can take meaningful steps toward improved care, prevention and support.

Follow us to learn more about our mission to combat neurodegenerative diseases.

10/19/2023

Alzheimer's is a multi-stage journey, each with its own unique challenges.

From the initial memory lapses to the profound cognitive decline in the final stage, this journey is marked by its complexities.

Click through to explore each stage in detail and visit our website to learn more about our fight against Alzheimer’s.